CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: We have now demonstrated that pimozide, an FDA-approved anti-psychotic drug that is used in the treatment of a wide range of diseases [64] and could be potentially used to treat chronic myeloid leukemia, in which it specifically targets cancer cells, without affecting CD34+ hematopoietic stem cells [34].